ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Conjunctivitis
Dust Mite Allergy

Asthma trials near Taipei City, TWN:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 87 other locations

and clinical activity of FB704A in adult patients with severe asthma. The study comprised a 4-week screening period, a 8-week treatment peri...

Enrolling
Severe Asthma
Biological: FB704A
Biological: FB704A placebo

Phase 2

Oneness Biotech

Taipei, Taiwan and 6 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Taipei, Taiwan and 335 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Active, not recruiting
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Taipei, Taiwan and 282 other locations

1. Eosinophilic asthma, a type 2 immune disorder, often involves the excessive production of type 2 cytokines.2. Excessive Type 2 cytokines ...

Not yet enrolling
Eosinophilic Asthma
Other: Formulation buffer
Biological: AD17002

Phase 2

Advagene Biopharma

Taipei, Taiwan, Taiwan

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

Taipei, Taiwan and 154 other locations

placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma...

Enrolling
Allergic Asthma
Biological: FB825
Other: Placebo

Phase 2

Oneness Biotech

Taipei, Taiwan and 15 other locations

per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma...

Enrolling
Mild Asthma
Other: Methacholine
Other: Albuterol Sulfate inhalation Placebo
Intech Biopharm

Taipei City, Taiwan and 11 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Active, not recruiting
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 195 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Short-Acting Beta Agonists (SABA)
Drug: Fluticasone/salmeterol

Phase 2

Sanofi
Sanofi

Taipei, Taiwan and 231 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems